EUVIMEDEUVIMED entdecken
Crossref

Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine

Samira S Valvassori, Richard T da Rosa, Gustavo C Dal-Pont, Roger B Varela, Gustavo A Mastella, Thiani Daminelli, Gabriel R Fries, João Quevedo, Alexandra I Zugno iD

International Journal of Developmental Neuroscience · 2023

DOI: 10.1002/jdn.10296 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, 2023. Verfasst von Samira S Valvassori und 8 weiteren Autor:innen. Beteiligte Einrichtung: Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Br…. Hauptthemen laut MEDLINE: Schizophrenia, Ketamine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil, Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study aimed to evaluate Haloperidol's (Hal) effects on the behavioral, neurotrophic factors, and epigenetic parameters in an animal model of schizophrenia (SCZ) induced by ketamine (Ket). Injections of Ket or saline were administered intraperitoneal (once a day) between the 1st and 14th days of the experiment. Water or Hal was administered via gavage between the 8th and 14th experimental days. Thirty minutes after the last injection, the animals were subjected to behavioral analysis. The activity of DNA methyltransferase (DNMT), histone deacetylase (HDAC), and histone acetyltransferase and levels of brain‐derived neurotrophic factor (BDNF), nerve growth factor (NGF), neurotrophin‐3 (NT‐3), and glial‐derived neurotrophic factor (GDNF) were evaluated in the frontal cortex, hippocampus, and striatum. Ket increased the covered distance and time spent in the central area of the open field, and Hal did not reverse these behavioral alterations. Significant increases in the DNMT and HDAC activities were detected in the frontal cortex and striatum from rats that received Ket, Hal, or a combination thereof. Besides, Hal per se increased the activity of DNMT and HDAC in the hippocampus of rats. Hal per se or the association of Ket plus Hal decreased BDNF, NGF, NT‐3, and GDNF, depending on the brain region and treatment regimen. The administration of Hal can alter the levels of neurotrophic factors and the activity of epigenetic enzymes, which can be a factor in the development of effect collateral in SCZ patients. However, the precise mechanisms involved in these alterations are still unclear.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SchizophreniaKetamineHumansRatsAnimalsHaloperidolBrain-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic FactorNerve Growth FactorDisease Models, AnimalEpigenesis, Genetic

Stichwörter der Autor:innen

epigenetichaloperidolneurotrophic factorschizophrenia

Substanzen

HaloperidolKetamineBrain-Derived Neurotrophic FactorGlial Cell Line-Derived Neurotrophic FactorNerve Growth Factor

Autor:innen und Institutionen

  • Translational Psychiatry Laboratory, Graduate Program in Health Sciences, University of Southern Santa Catarina (UNESC), Criciúma, Santa Catarina, Brazil.
  • Translational Psychiatry Program, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, USA.
  • Center of Excellence on Mood Disorders, Faillace Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center at Houston (UTHealth), Houston, Texas, USA.
  • Neuroscience Graduate Program, University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.

ORCID-Profile: Alexandra I Zugno

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil
  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina
  • Instituto Cérebro e Mente
  • Universidade do Extremo Sul Catarinense
  • Instituto Mente e Cérebro - Neurociência

Zitieren

APA

Valvassori, S. S., da Rosa, R. T., Dal-Pont, G. C., Varela, R. B., Mastella, G. A., Daminelli, T., Fries, G. R., Quevedo, J., & Zugno, A. I. (2023). Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.10296

Vancouver

Valvassori SS, da Rosa RT, Dal-Pont GC, Varela RB, Mastella GA, Daminelli T, et al. Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine. International Journal of Developmental Neuroscience. 2023. doi:10.1002/jdn.10296

BibTeX
@article{Valvassori2023,
  author = {Valvassori, Samira S and da Rosa, Richard T and Dal-Pont, Gustavo C and Varela, Roger B and Mastella, Gustavo A and Daminelli, Thiani and Fries, Gabriel R and Quevedo, João and Zugno, Alexandra I},
  title = {Haloperidol alters neurotrophic factors and epigenetic parameters in an animal model of schizophrenia induced by ketamine},
  journal = {International Journal of Developmental Neuroscience},
  year = {2023},
  doi = {10.1002/jdn.10296}
}
Kostenlos starten →